Medicine

The FDA warned health professionals last month that the drug should not be used outside of hospital or research settings, due to sometimes fatal side effects.

A Massachusetts company says its experimental vaccine against the coronavirus showed encouraging results in very early testing.

Testing more people is important, but a negative result does not necessarily mean someone is in the clear.

Health networks say they are now better prepared with COVID-19 tests and precautions, so can slowly bring patients for in-person visits and procedures.

The announcement was big news for Pa. hospitals, which has seen other states get the antiviral — the first somewhat effective coronavirus treatment.

Gilead has donated its existing supply, to be distributed by AmerisourceBergen. That company says the government decides which places can get the drug.

Would-be ER visitors are weighing their fear of worsening symptoms with their fear of exposure to the coronavirus. Doctors say that’s not a good thing.

Why one expert believes the termination of the Fox Chase Cancer Center sale is just the start of some tough times for hospitals.

Does signing a form expressing a religious objection to providing birth control to employees burden the religious freedom of employers as much as paying for the birth control?

Stephen K. Klasko, CEO of Jefferson Health, called the cancellation of the deal with Temple University “the latest casualty of COVID-19.”

A U.S. government scientist says he was ousted for resisting political pressure to allow use of a malaria drug to battle COVID-19 despite scant evidence it would work.

Instead, the state is focusing on providing personal protective equipment to nursing homes, which have been hard hit by the pandemic.

The FDA authorized Friday the emergency use of remdesivir for patients with severe cases of COVID-19. Drugmaker Gilead Sciences' lobbying hit a new high in the first quarter.

Remdesivir is the first drug shown to help fight COVID-19, which has killed more than 230,000 people worldwide.

Blood donations by African Americans dropped by 50% since mid-March, when many drives were canceled. That affects sickle cell patients seeking a match.